Otolaryngology Doctors in Oakland, CA Accepting Medicare

24 Otolaryngology doctors found. Showing 21 - 24

Dr. Daniel Lawrence Monin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6400

Deepak Gurushanthaiah, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000

Dr. Robert F. Gray, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000    Fax: 209-249-6646

Jonathan Liang, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000

News Archive

10-year results from clinical trial of extended letrozole therapy for women with HR+ breast cancer

In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.

Study reveals long-term advantages of fast initial weight loss

If you thought the best way to lose and maintain weight was the slow and steady approach, think again. A new study by Lisa Nackers and colleagues, from the University of Florida in the US, suggests that the key to long-term weight loss and maintenance is to lose weight quickly, not gradually, in the initial stages of obesity treatment. Their findings1 are published online in Springer's International Journal of Behavioral Medicine.

Blair House bipartisan meeting on health insurance reform: Speaker Pelosi's remarks

"As we sit around this table, I think we should be mindful of what they do when they sit around their kitchen table. What we do here must be relevant to their lives. And for them, they don't have time for us to start over. Many of them are at the end of the line with their insurance…I just hope that as we sit around this table, we understand the urgency that the American people have about this issue, how it affects not only their health, but their economic security."

First clinical trial data of a fully bioabsorbable drug-eluting stent

Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.

Catatonia may cause regression in Down syndrome patients

Down syndrome, the most common chromosomal disorder in America, can be complicated by significant deterioration in movement, speech and functioning in some adolescents and young adults. Physicians previously attributed this regression to depression or early-onset Alzheimer's, and it has not responded to treatments.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)